 |
   |
|
ScienceDaily (July 10, 2008) — A new University of Michigan study in mice suggests that a drug recently approved to fight cancer tumors is also able to reduce the effects of graft-versus-host disease, a common and sometimes fatal complication for people who have had bone marrow transplants. For the full article, click here.
|